News & Updates

Having greater serum folic acid levels and taking folic acid supplements more than once a week during the second and third trimesters appear to lower the risk of Kawasaki disease among infants, according to a study.

Administering the new-generation thrombolytic reteplase within 4.5 hours of acute ischaemic stroke onset appears to be safe and as efficacious as alteplase, according to a phase II study.

Adding subcutaneous daratumumab to the three-drug regimen containing bortezomib, lenalidomide, and dexamethasone (VRd) appears to improve outcomes for transplant-eligible patients with newly diagnosed multiple myeloma (MM), with extended disease-free periods and increased depth of response, according to the phase III PERSEUS trial.